The Robson Lab was established by Prof. Tracy Robson in 2004 in the School of Pharmacy, Queen’s University of Belfast, Northern Ireland. In 2016, following Prof. Robson’s appointment as Head of Department, the Robson Lab moved to the Department of Molecular and Cellular Therapeutics (MCT), at RCSI University of Medicine and Health Sciences, Dublin, Ireland. In 2019 MCT merged with the former School of Pharmacy to form the new and innovative School of Pharmacy and Biomolecular Sciences, where Prof. Robson is Head of School. Our lab is based in newly refurbished molecular biology labs, with state-of-the-art facilities in RCSI building 123 St. Stephen’s Green.
Our lab comprises of numerous research themes with a common focus on the biology of a protein called FK506 Binding Protein Like (or FKBPL). Overall, our aim is to understand and harness the known protective anti-inflammatory and anti-cancer effects of FKBPL to therapeutically treat a whole plethora of conditions, including cancer, vascular disease, inflammatory disorders and obesity.